Information Provided By: 
Fly News Breaks for September 10, 2015
FLDM
Sep 10, 2015 | 08:12 EDT
Leerink analyst Dan Leonard lowered his estimates for Fluidigm to reflect longer sales cycle for new products but is a buyer of the stock at current levels. Fluidigm is "one of the most interesting small-cap stories in life science tools" heading into 2016, the analyst tells investors. He keeps an Outperform rating on the name with a $28 price target.
News For FLDM From the Last 2 Days
There are no results for your query FLDM
